Arbeit Robert D. 4
4 · IDERA PHARMACEUTICALS, INC. · Filed Nov 15, 2012
Insider Transaction Report
Form 4
Arbeit Robert D.
VP Clinical Development
Transactions
- Award
Stock Option (Right to Buy)
2012-11-13+25,125→ 109,500 totalExercise: $1.16Exp: 2021-11-28→ Common Stock (25,125 underlying)
Footnotes (1)
- [F1]On December 5, 2011, the reporting person was granted an option to purchase up to an aggregate of 150,000 shares of common stock. Half of the shares subject to such option are subject to satisfaction of performance vesting criteria. On November 13, 2012, certain performance vesting criteria were met with respect to 25,125 of such shares, of which 6,281 shares vested on November 13, 2012 and the remaining 18,844 of which will vest in three equal annual installments beginning on November 13, 2013.